Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary. - Wikidata - awgldk - TriplyDB

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

http://www.wikidata.org/entity/Q37776738

about

Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives Promyelocytic leukemia (PML) protein plays important roles in regulating cell adhesion, morphology, proliferation and migration Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival.S100 and annexin proteins identify cell membrane damage as the Achilles heel of metastatic cancer cells.Muscadine Grape Skin Extract Induces an Unfolded Protein Response-Mediated Autophagy in Prostate Cancer Cells: A TMT-Based Quantitative Proteomic Analysis.Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.Annexin A4 is involved in proliferation, chemo-resistance and migration and invasion in ovarian clear cell adenocarcinoma cells.Annexin A4 is a promising therapeutic target for the treatment of platinum-resistant cancers.The role of annexin A2 in tumorigenesis and cancer progression Annexin A4-conferred platinum resistance is mediated by the copper transporter ATP7A.Annexin A6 interacts with p65 and stimulates NF-κB activity and catabolic events in articular chondrocytes.Prognostic impact of AnxA1 and AnxA2 gene expression in triple-negative breast cancer.

P2860

Q26775315-1EFABB6F-C0CB-4791-B548-5614E330F265 Q28588291-D88B0150-07AA-438D-909E-E6F65B8A2514 Q34496963-557EA201-3A57-4AA6-BFC7-E653B9015919 Q35141257-67DBF66F-2A4C-445D-9B2E-9E16F658CAAF Q36166133-60E7C212-CABD-479F-98DE-DC71E31FA094 Q37148314-DFD35C2D-1CC5-40DD-8F07-B885027F33A9 Q37296914-017FE598-B07F-4A06-9C1F-8C4D755F2035 Q38183430-82AC0982-3C4F-435B-B656-FAF04CE51F3D Q38366258-2596BDF3-4087-48AE-8C39-5C8F9616186E Q39073167-63079DFB-83BC-4FB0-96E4-8B6F717131A2 Q45992691-8DD218FB-96C6-4628-94B4-7499C5061F8B Q49270446-4D9CF915-66F4-4BAF-8BE4-527FCB1950AD

P2860

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

http://www.wikidata.org/entity/Q37776738

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

@en

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

@nl

type

label

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

@en

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

@nl

prefLabel

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

@en

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary.

@nl

P1433

Q37776738-E87B4F26-8217-405D-8001-A078B86A6344

P1476

Q37776738-F055AA73-64AE-4F1D-846A-8F696584E464

P2093

Q37776738-341BD703-4705-4440-B2C5-FD76F6D1FF80

Q37776738-9C2E5545-E5BC-46FF-A01C-47E9DB13F4B8

P2860

Q37776738-0077DB84-CFE6-44FA-A923-E49CBF25F432

Q37776738-04CBA168-B226-4311-92F7-DC73892ED705

Q37776738-1321C2B8-B909-4E89-B429-A268EAC0BD92

Q37776738-1369B9DE-F58F-4AB8-8A2D-89344FD6A590

Q37776738-23E8809D-F535-4551-BFA9-7A234CF0617C

Q37776738-25968FF9-FB58-40E5-9840-1B6512A65BA8

Q37776738-26FE9B8F-7A7C-4E20-A398-283C739BA037

Q37776738-31A35B9B-03C3-4ABF-9D4B-2AA5D511292A

Q37776738-34097A81-BA31-4305-802A-AB90D743F8AC

Q37776738-3A5FC198-E583-4E4B-B4A1-3E4BDD92DD57

P304

Q37776738-EEF81889-D202-48F7-83ED-0A5179B53925

P31

Q37776738-A658DBA2-85B2-4D50-ABE4-324FF46EB0B9

P356

Q37776738-4294E545-788F-4D83-A3EE-4FCAECD9E10E

P407

Q37776738-DFED3394-83AB-4B02-B2D3-29BDBBDF30ED

P433

Q37776738-13887851-5E2B-4472-BEA8-65AF4B0146B5

P478

Q37776738-3469C50A-083E-4CE0-90BD-21A9EEC6D50A

P50

Q37776738-B8C37017-191E-4550-8F9F-94B2923ECCD4

Q37776738-D2C28B9F-9DD8-4A50-A834-5711B8746C57

P577

Q37776738-C96A4653-0BB4-4903-A8E2-4D0D0E120B04

P698

Q37776738-5BF7C483-33F0-4E19-86C3-2B8C4B7FCD54

P356

14728222.2010.511180

P1433

Expert Opinion on Therapeutic Targets

P1476

Targeting annexin A4 to counteract chemoresistance in clear cell carcinoma of the ovary

@en

P2093

Ayako Kim

http://www.w3.org/2001/XMLSchema#string

Takayuki Enomoto

http://www.w3.org/2001/XMLSchema#string

P2860

Annexin A4 interacts with the NF-kappaB p50 subunit and modulates NF-kappaB transcriptional activity in a Ca2+-dependent manner

Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls

Modulation of paclitaxel resistance by annexin IV in human cancer cell lines

Phosphorylation mutants elucidate the mechanism of annexin IV-mediated membrane aggregation

Global cancer statistics, 2002

Nuclear factor-kappaB in cancer development and progression

Annexins: from structure to function

Annexins: linking Ca2+ signalling to membrane dynamics

Progress and challenges in screening for early detection of ovarian cancer.

Application of fluorescence difference gel electrophoresis saturation labelling for the analysis of microdissected precursor lesions of pancreatic ductal adenocarcinoma.

P304

963-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2010.511180

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20673185

http://www.w3.org/2001/XMLSchema#string